Indranil Dey bought $25k of BJDX
President and CEO at Bluejay Diagnostics, Inc.. 12,500 shares at an average of $2.00, traded Mar 14, 2026, filed May 18, 2026.
Score components
- +25RoleCEO
- +5Trade size$25k at market
- +10Relative to holdingsHoldings up 56818%
- 0Price contextNo price history yet
- +15Cluster5 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001123292-26-000689, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 14, 2026 | POpen-market purchase Common Stock | +12,500 | $2.00 | $25k | 12,522 | May 18, 2026 |
Related signals
Other insiders at Bluejay Diagnostics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | BJDXbuy Bluejay Diagnostics, Inc. | Hrt Financial LP owner | $97k 64,047 shares | +102% | |
| 29Weak | BJDXsell Bluejay Diagnostics, Inc. | Hrt Financial LP owner | $49k 34,938 shares | -28% | |
| 45Moderate | Bluejay Diagnostics, Inc. | Svetlana Dey director | $25k 12,500 shares | first purchase | |
| 43Moderate | Bluejay Diagnostics, Inc. | Fred S Zeidman director | $25k 12,500 shares | - | |
| 45Moderate | Bluejay Diagnostics, Inc. | Donald R Chase director | $25k 12,500 shares | first purchase | |
| 45Moderate | Bluejay Diagnostics, Inc. | Douglas Clark Wurth director | $25k 12,500 shares | first purchase | |
| 51Moderate | Bluejay Diagnostics, Inc. | Indranil Dey President and CEO | $1,635 500 shares | +2% | |
| 51Moderate | Bluejay Diagnostics, Inc. | Svetlana Dey director | $1,535 500 shares | +50% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.